Table 3 Prognostic significance of MRD... | American Society of Hematology

Table 3

Prognostic significance of MRD in methotrexate cohorts and of HD-MTX in MRD-positive and negative subjects

End-induction MRD	C-MTX 5-y EFS	HD-MTX 5-y EFS	P value
<0.01%	86% ± 2%	88% ± 2%	.19
≥0.01%	58% ± 4%	68% ± 4%	.008
P value	<.0001	<.0001	—

End-induction MRD	C-MTX 5-y EFS	HD-MTX 5-y EFS	P value
<0.01%	86% ± 2%	88% ± 2%	.19
≥0.01%	58% ± 4%	68% ± 4%	.008
P value	<.0001	<.0001	—